Vijaya Diagnostic Centre Ltd. · NSE:VIJAYA
Vijaya Diagnostic Centre — Q4 & FY25 Earnings Presentation
51 slides from Vijaya Diagnostic Centre's earnings presentation, May 12, 2025
Slide 1: Cover letter to stock exchanges
May 12, 2025 To, To, The Listing Department The Corporate Relations Department National Stock Exchange Of India Limited, BSE Limited, Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, 25th floor, Dalal Street, Bandra (East), Mumbai - 400 051 Mumbai - 400 001 NSE Symbol: VIJAYA BSE Scr
Slide 2: Q4 & FY25 Earnings Presentation
Q4 & FY25 Earnings Presentation May 12, 2025 Q2 & H1 FY25 Earnings Presentation, November 07, 2024
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: Disclaimer
Disclaimer Disclaimer Note 1: Acquisition (PH Diagnostic Centre Private Limited, Pune) : PH has become a whole owned subsidiary effective from 21st December 2023. Consequently, its financials have been consolidated from 21st December 2023 in the last financial year FY 2023-24. Hence, the consolidate
Slide 5: Q4 & FY25 Performance Snapshot
Q4 & FY25 Performance Snapshot Strategic Expansion
Slide 6: Q4 FY25 Performance Snapshot
Q4 FY25 Performance Snapshot Financial Performance Key Metrics INR 1,732 Mn INR 1,621 Mn 1.05 Mn 3.79 Mn Revenue from Operations Revenue excluding PH Footfall Tests INR 689 Mn | 39.8% INR 346 Mn | 20.0% 151 (2) 93% EBITDA | EBITDA Margin % PAT | PAT Margin % Centres B2C Revenue % YOY Growth % Geogra
Slide 7: FY25 Performance Snapshot
FY25 Performance Snapshot Financial Performance Key Metrics INR 6,814 Mn INR 6,356 Mn 4.19 Mn 14.79 Mn Revenue from Operations Revenue excluding PH Footfall Tests INR 2,732 Mn | 40.1% INR 1,431 Mn | 21.0% 151 (2) 93% EBITDA | EBITDA Margin % PAT | PAT Margin % Centres B2C Revenue % YOY Growth % Geog
Slide 8: Management Commentary
Management Commentary “ Vijaya reported another strong financial year with YOY growth of 24.4% and an organic growth of 18.9%. I’m happy to announce the successful launch of 6 hubs in the last 2 months - 2 each in Pune, West Bengal and Bengaluru. Additionally, the execution of 3 more hubs in West Be
Slide 9: Key Financial Highlights – Q4 & 12M FY25
Key Financial Highlights – Q4 & 12M FY25 Revenue from Operations (INR Mn) EBITDA & EBITDA Margin % PAT & PAT Margin % 40.7% 39.7% 39.8% 40.3% 40.1% 21.6% 20.8% 20.0% 21.7% 21.0% 6,814 5,478 2,732 Key 1,431 2,209 1,188 Financials 1,552 1,690 1,732 631 671 689 335 352 346 Q4 FY24 Q3 FY25 Q4 FY25 FY24
Slide 10: Key Operational Highlights
Key Operational Highlights Tests Performed (# in Mn) Footfalls (# in Mn) Tests / Footfalls (# in Mn) 4.19 3.62 14.79 3.55 3.52 3.53 11.89 3.44 3.35 3.36 3.68 3.79 0.98 1.05 1.05 Q4 FY24 Q3 FY25 Q4 FY25 FY24 FY25 Q4 FY24 Q3 FY25 Q4 FY25 FY24 FY25 Q4 FY24 Q3 FY25 Q4 FY25 FY24 FY25 Revenue per Test (IN
Slide 11: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement (INR Mn) Particulars Q4 FY25 Q4 FY24 Y-o-Y Q3 FY25 Q-o-Q FY25 FY24 Y-o-Y Revenue from operations 1,732.4 1,552.1 11.6% 1,689.8 2.5% 6,813.9 5,478.1 24.4% Cost of materials consumed 221.7 188.1 17.8% 208.5 6.3% 847.6 654.4 29.5% Employee benefits expense 284.0 245
Slide 12: Key Developments
Key Developments Strategic Expansion
Slide 13: Inaugurated a state-of-the-art Hub in Ambegaon, Pune
1 Inaugurated a state-of-the-art Hub in Ambegaon, Pune Full Fledged Operations in Ambegaon started in the 1st week of April, 2025 in line with our strategy of expansion in Pune post PH acquisition Ambegaon 14,000+ sq.ft. Hub Also houses back-end houses advanced support services like call equipment l
Slide 14: Inaugurated a state-of-the-art Hub in HSR Layout, Bengaluru
2 Inaugurated a state-of-the-art Hub in HSR Layout, Bengaluru Inaugurated State-of-the-Art Hub in HSR Layout in the 3rd week of April, 2025 in line with our strategy of expanding organically in Bengaluru HSR Layout 8,500+ sq.ft. Hub Strategically located houses advanced closer to major IT Hubs equip
Slide 15: Inaugurated a state-of-the-art Hub in Yelahanka, Bengaluru
3 Inaugurated a state-of-the-art Hub in Yelahanka, Bengaluru Inaugurated State-of-the-Art Hub in Yelahanka in the 3rd week of April, 2025 in line with our strategy of expanding organically in Bengaluru Yelahanka Located closer to the 7,500 sq.ft. Hub airport with rising houses advanced residential &
Slide 16: Inaugurated a state-of-the-art Hub in Krishnanagar, West Bengal
4 Inaugurated a state-of-the-art Hub in Krishnanagar, West Bengal Inaugurated State-of-the-Art Hub in Krishnanagar in the 2nd week of May, 2025 in line with our strategy of creating dense network in West Bengal Krishnanagar 6,000+ sq.ft. Hub Locality is popular for houses advanced established diagno
Slide 17: Inaugurated a state-of-the-art Hub in Barasat, Kolkata
5 Inaugurated a state-of-the-art Hub in Barasat, Kolkata Inaugurated State-of-the-Art Hub in Barasat in the 2nd week of May, 2025 in line with our strategy of creating dense network in West Bengal Barasat 6,000+ sq.ft. Hub The area serves as a houses advanced major transit hub being equipment like 3
Slide 18: Inaugurated a state-of-the-art Hub in Kalyani Nagar, Pune
6 Inaugurated a state-of-the-art Hub in Kalyani Nagar, Pune Inaugurated State-of-the-Art Hub in Kalyani Nagar in the 2nd week of May, 2025 in line with our strategy of expansion in Pune post PH acquisition Kalyani Nagar 10,500+ sq.ft. Hub Strategically located houses advanced closer to major IT Hubs
Slide 19: Launched a Spoke in Pimple Saudagar, Pune
7 Launched a Spoke in Pimple Saudagar, Pune Inaugurated a Spoke in Pimple Saudagar in February, 2025 in line with our strategy of strategy of expansion in Pune post PH acquisition Pimple The spoke 1,800+ sq.ft. Spoke houses enhances our machinery for X-Ray, ECG Pune market and all kinds of Lab Tests
Slide 20: Launched a Spoke in Dhanori, Pune
8 Launched a Spoke in Dhanori, Pune Inaugurated a Spoke in Dhanori in 4th week of April, 2025 in line with our strategy of strategy of expansion in Pune post PH acquisition Dhanori The spoke 2,600+ sq.ft. Spoke houses enhances our machinery for X-Ray, ECG Pune market and all kinds of Lab Tests footp
Slide 21: Strategic Expansion
Strategic Expansion Strategic Expansion
Slide 22: Expanding Strategically in Alignment with our Vision
Expanding Strategically in Alignment with our Vision Inorganic Expansion Strategy • Successfully acquired PH, Pune's largest B2C integrated diagnostic chain • This strategic acquisition seamlessly aligns East India Strategy with our commitment to providing top-notch healthcare services at affordable
Slide 23: Expansion Plans - Upcoming Hubs and Spokes Centres
Expansion Plans - Upcoming Hubs and Spokes Centres Tentative Timelines for Geography Count & Type H1 FY26 Commencement Pune 1 Hub & 1 Spoke H1 FY26 (1) 8 1 Hubs Spoke H2 FY26 5 Hubs H1 FY26 (2) West Bengal 2 2 Bengaluru 2 Hubs H1 FY26 (1) Hubs Spokes RoAPT 2 Hubs Total H2 FY26 FY26 Hyderabad 2 Spoke
Slide 24: Company Overview
Company Overview Strategic Expansion
Slide 25: Vijaya at a Glance
Vijaya at a Glance Vijaya Diagnostic is the largest integrated B2C focused diagnostic chain in India with 151 state-of-the-art centres spread across 25 cities & towns Evolved from a regional player to a player with presence in multiple geographies … … While retaining its core values of providing Qua
Slide 26: Our Journey
Our Journey 1981 1993 1995 2007 20032012 2005 2016 ▪ Vijaya Diagnostic Centre ▪ Became 1st Independent diagnostic ▪ Recognized as one of the Best ▪ Received investment from incorporated in Hyderabad centre in South India to offer PET CT Imaging centres in Hyderabad Karakoram Limited & Kedaara from W
Slide 27: Integrated Diagnostics Player Offering One-Stop Solution
Integrated Diagnostics Player Offering One-Stop Solution Complete Range of Diagnostic Services under One Roof Robust operational network enables us to offer integrated, high-quality diagnostic services that significantly elevate the customer experience 37% Pathology (1) 63% Radiology (1) 26 1. Reven
Slide 28: Dominant Position in Telangana & AP Markets with a Strong Brand Recall
Dominant Position in Telangana & AP Markets with a Strong Brand Recall … Vijaya has been successful in creating a dense market consolidating its foothold in its core geographies of AP & Telangana markets Present in Key Geographies of AP & Telangana 72 (1) % Hyderabad Revenue Contribution Nizamabad M
Slide 29: Driving Geographical Diversification through Strategic Expansion
… and Driving Geographical Diversification through Strategic Expansion Gurgaon Hyderabad Pune RoAPT West Bengal Kalaburagi 78% 83% 72% 18% 17% 14% Geographical 6% Revenue Mix 2% 4% 3% 2% 0% FY25 FY24 FY23 FY25 FY24 FY23 FY25 FY24 FY23 FY25 FY24 FY23 Vijaya is well-placed to attract customers in new
Slide 30: Best-in-class Online Services & Home Collections
Boosting Accessibility with Best-in-class Online Services & Home Collections Online Services Home Collections Enhancing Customer Experience through Seamless Online App, E-Commerce Website and Call Centre Bookings Elevating Customer Experience through Home Collections Access to reports online & histo
Slide 31: Robust Technical Capabilities with State-of-the-art IT Infrastructure
Robust Technical Capabilities with State-of-the-art IT Infrastructure 34 9 Advanced Software to Manage Clinical Data CT Machines PET CT / Gamma machines 34 300+ MRI Machines Fully Integrated Radiology Radiologists, Lab Doctors & Advance Laboratory Information Systems (RIS) and Physicians Information
Slide 32: Transitioned to AI Power Pack Radiology Software in FY25
Transitioned to AI Power Pack Radiology Software in FY25 Digitised Images Digitised Reports High Quality Reports Faster TAT ▪ Digitised Radiology images ▪ Radiology test reports can be ▪ Since the work list is ▪ Helps enhance customer can be shared with the accessed online by the centralised, it can
Slide 33: Experienced Board of Directors
Experienced Board of Directors Ms. Suprita Reddy Dr. S. Surendranath Reddy Mr. Sunil Chandra Kondapally S Geeta Reddy Managing Director & Chief Founder & Exec. Chairman Executive Director Non-Executive Director Executive Officer ✔ 40+ years of experience ✔ 22+ years of experience ✔ 35+ years of expe
Slide 34: Stellar Management Team
Stellar Management Team Ms. Suprita Reddy Mr. Sunil Chandra Dr. S. Surendranath Reddy Mr. Sai Srinivas Lanka Managing Director & Chief Kondapally Founder & Exec. Chairman Chief Technology Officer Executive Officer Executive Director ✔ 40+ years of experience ✔ 22+ years of experience ✔ 22+ years of
Slide 35: Shareholding Pattern as at 31st March, 2025
Shareholding Pattern as at 31st March, 2025 Shareholding Pattern as at 31st March, 2025 Others 4.0% FIIs 19.3% Promoter & Promoter Group 53.0% DIIs 23.7% DIIs: Mutual Funds, AIFs and QIBs FIIs: Hedge Funds, Sovereign Wealth Funds, Foreign MFs, Pension Funds, Trusts and AMCs Others: Retail, Bodies Co
Slide 36: Doctors Connect Program in Q4 FY25
Doctors Connect Program in Q4 FY25 Vijaya Diagnostic organised a webinar on the potential of Cardiac MRI in Vijaya Diagnostic organised a webinar on Imaging of articular cartilage detection and evaluation of Ischaemic heart disease Vijaya Diagnostic organised a webinar on understanding HMPV virus &
Slide 37: Awards & Accolades
Awards & Accolades Fastest Growing Leaders 2023- Fastest Growing Brands 2023- Icon in Integrated Diagnostic Most Preferred Workplace for Most Trusted Brand of India 24 awarded at Asian business & 24 awarded at Asian business & Services by Times Health Women 2024 – 25 recognized 2024-25 awarded by So
Slide 38: Disclaimer
Disclaimer Note 2: Disclaimer "With effect from 01 January 2023, the Company has changed its method of depreciation on all Property, Plant and Equipment from Written Down Value (“WDV") method to Straight Line Method (“SLM"), based upon the technical assessment of expected pattern of consumption of t
Slide 39: Annexure
Annexure Strategic Expansion
Slide 40: State-of-the-art Infrastructure (1/3)
State-of-the-art Infrastructure (1/3) 39
Slide 41: State-of-the-art Infrastructure (2/3)
State-of-the-art Infrastructure (2/3) 40
Slide 42: State-of-the-art Infrastructure (3/3)
State-of-the-art Infrastructure (3/3) 41
Slide 43: Advanced Equipment in Place to Deliver High Quality Services (1/2)
Advanced Equipment in Place to Deliver High Quality Services (1/2) 42
Slide 44: Advanced Equipment in Place to Deliver High Quality Services (2/2)
Advanced Equipment in Place to Deliver High Quality Services (2/2) 43
Slide 45: Robust Operational Metrics
Robust Operational Metrics Diagnostic Centre (Nos) Footfalls (Mn) Tests Performed (Mn) 4.19 145 151 3.62 3.55 14.79 121 3.18 11.89 95 2.63 10.05 9.32 80 7.09 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 Test per Footfall (Nos) Revenue per Test (INR) Revenue per Footfall
Slide 46: Consistent Financial Performance
Consistent Financial Performance (INR Mn) Revenue EBIDTA PAT CAGR:16.0% CAGR:13.3% CAGR:14.1% 6,814 2,732 5,478 2,037 2,209 1,431 4,624 4,592 1,660 1,820 1,097 1,188 3,767 845 846 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 EBIDTA Margin (%) PAT Margin (%) 22.4% 23.7%
Slide 47: Sustainable Cash Generation & Increasing Return Ratios
Sustainable Cash Generation & Increasing Return Ratios Surplus Cash CFO (1) / EBIDTA (%) (INR Mn) 2,466 2,554 90% 2,277 1,985 1,822 83% 82% 78% 77% FY21 FY22 FY23 FY 24 FY 25 FY21 FY22 FY23 FY24 FY25 RoCE Pre-Tax (2) (%) RoE (%) 32% 31% 23% 23% 25% 25% 18% 18% 22% 16% FY21 FY22 FY23 FY24 FY25 FY21 F
Slide 48: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account (INR Mn) Particulars FY21 FY22 FY23 FY24 FY25 Revenue from operations 3,767 4,624 4,592 5,478 6,814 Cost of materials consumed 571 715 589 654 848 Employee benefits expense 574 707 785 902 1,122 Other expenses 962 1,165 1,398 1,712 2,113 EBITDA 1,660 2,037 1,820 2,
Slide 49: Consolidated Balance Sheet
Consolidated Balance Sheet (INR Mn) Assets Mar-21 Mar-22 Mar-23 Mar-24 Mar-25 Equity & Liabilities Mar-21 Mar-22 Mar-23 Mar-24 Mar-25 NON-CURRENT ASSETS 3,022 4,436 5,777 7,714 9,664 EQUITY 3,592 4,695 5,466 6,599 7,993 Property, plant and equipment 1,358 1,966 2,940 3,785 4,469 Equity share capital
Slide 50: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement (INR Mn) Particulars Mar-21 Mar-22 Mar-23 Mar-24 Mar-25 Cash Flow from Operating Activities Profit before Tax 1,121 1,474 1,135 1,587 1,932 Adjustment for Non-Operating Items 534 572 683 599 786 Operating Profit before Working Capital Changes 1,655 2,046 1,818 2,186
Slide 51: Thank You
Thank You For further information please contact: Mr. Dhiren Gala AGM - Strategy & Investor Relations +91 90598 93206 dhiren.g@vijayadiagnostic.in ir@vijayadiagnostic.in www.vijayadiagnostic.com Corporate Office : #6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082, Telangana
Vijaya Diagnostic Centre — Q4 & FY25 Earnings Presentation on 6ix